Aromasin, also known by its generic name exemestane, plays a crucial role in the management of hormone receptor-positive breast cancer. It is essential in the context of estrogen-driven tumor growth. By selectively inhibiting the aromatase enzyme, Aromasin effectively lowers the levels of estrogen in the body, which is pivotal for slowing down or stopping the proliferation of cancer cells.
Aromasin is a medication classified as an aromatase inhibitor, specifically containing the active ingredient exemestane. It works by reducing the production of estrogen in the body, which can be beneficial in the treatment of hormone receptor-positive breast cancer. To explore a catalog of Aromasin products available online, visit Aromasin online catalog england pharmacy.
How Aromasin Works
The pharmacological action of Aromasin can be summarized as follows:
- Aromatase Inhibition: Aromasin binds to the aromatase enzyme, preventing it from converting androgens into estrogens in peripheral tissues.
- Reduced Estrogen Levels: This inhibition leads to significantly reduced circulating estrogen levels in the body, creating an unfavorable environment for estrogen-dependent tumors.
- Effects on Tumor Growth: By lowering estrogen, Aromasin slows down the growth of hormone-sensitive breast cancer cells, making it a vital option post-surgery and for metastatic cases.
Clinical Applications
Aromasin is primarily prescribed for:
- Postmenopausal women with hormone receptor-positive breast cancer.
- Adjuvant treatment to prevent recurrence after surgery.
- Treatment of metastatic breast cancer in patients who have progressed on other therapies.
Conclusion
Aromasin represents a significant advancement in the treatment landscape for hormone receptor-positive breast cancer, offering a targeted approach to therapy through its pharmacological action as an aromatase inhibitor.